SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-093195
Filing Date
2024-04-11
Accepted
2024-04-11 16:06:08
Documents
5
Effectiveness Date
2024-04-11

Document Format Files

Seq Description Document Type Size
1 S-8 d816662ds8.htm S-8 46393
2 EX-5.1 d816662dex51.htm EX-5.1 9742
3 EX-23.2 d816662dex232.htm EX-23.2 1642
4 EX-FILING FEES d816662dexfilingfees.htm EX-FILING FEES 18524
5 GRAPHIC g816662snap1.jpg GRAPHIC 3734
  Complete submission text file 0001193125-24-093195.txt   82703
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278619 | Film No.: 24838548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)